We found that the pathways associated with tumor malignancy, such as G2M_CHECKPOINT, E2F_TARGETS, and MYC_TARGETS_V2, were upregulated in Cluster B by GSVA pathway analysis, potentially resulting in poorer prognosis (Figure 1J). This evidence concerns the gene MYC and neoplasm.